Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Bech Pharma Consulting AB
AB
Active
Org 5591979355
Pirgatan 13
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2019
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 7K
-21% vs 2024
EBITDA margin
-153.3%
-18% vs 2024
Equity ratio
74.4%
Financial strength
Net profit 2025
SEK 319
-52% vs 2024
EBITDA — year on year
SEK millions
0M
0M
1M
1M
1M
0M
2019
1M
+100%
2020
0M
-100%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 7K
-21%
EBITDA
SEK -11K
-18%
Net profit
SEK 319
-52%
Total assets
SEK 996K
-1%
Equity
SEK 741K
+0%
Employees
1
—
Company information
Legal name
Bech Pharma Consulting AB
Org number
5591979355
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
8 mars 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet inom läkemedel och bioteknik
Contact
Address
Pirgatan 13
Email
maria.ohlander@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Karlshamn
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
1M
2019
2M
2020
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2019
1M
2020
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2019
2020
2021
2022
2023
2024
2025
Revenue
930
1 887
458
7
6
9
7
Staff expenses
—
—
—
—
—
−0
−0
EBITDA
149
594
420
−16
−13
−9
−11
Depreciation & amort.
−0
−0
−0
−0
—
—
—
EBIT
149
594
420
−16
−13
−9
−11
Net financials
—
—
—
—
−0
5
0
Profit before tax
112
447
315
2
2
3
2
Tax
−24
−96
−65
−1
−2
−2
−1
Net profit
88
351
250
1
0
1
0
Balance sheet
SEK thousands
Item
2019
2020
2021
2022
2023
2024
2025
Total assets
452
1 126
1 181
1 065
1 014
1 009
996
Equity
138
488
738
740
740
741
741
Long-term debt
0
0
0
0
—
—
—
Short-term debt
277
452
153
54
17
18
18
Total debt
277
452
153
54
17
18
18
Financial ratios
5-year trend
EBITDA margin
-153.3%
This company
15.8%
Market median
-1070% vs market
2019
2025
Equity ratio
74.4%
This company
38.2%
Market median
+95% vs market
2019
2025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2019
2025
Net profit margin
4.4%
This company
8.1%
Market median
-46% vs market
2019
2025
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
2019
2025
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
2019
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-03-01 – 2019-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
EM
Eva Maria Bech
Board of Directors
2022
—
—
KI
Karin Ida Emelie Gustafsson
Board of Directors
2022
—
—
AM
Andrea Maria Aurora Ölander
Deputy Board Member
2022
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Bech Pharma Consulting AB also hold positions in
0
other companies.
Person
Role here
Other companies
Eva Maria Bech
Board of Directors
0 companies
Karin Ida Emelie Gustafsson
Board of Directors
0 companies
Andrea Maria Aurora Ölander
Deputy Board Member
0 companies